Robenacoxib

Robenacoxib, sold under the brand name Onsior, is a nonsteroidal anti-inflammatory drug (NSAID) used in veterinary medicine for the relief of pain and inflammation in cats and dogs.[1][2]

Robenacoxib
Names
IUPAC name
{5-Ethyl-2-[(2,3,5,6-tetrafluorophenyl)amino]phenyl}acetic acid
Identifiers
3D model (JSmol)
ChEBI
ChemSpider
ECHA InfoCard 100.210.035
Properties
C16H13F4NO2
Molar mass 327.279 g·mol−1
Pharmacology
QM01AH91 (WHO)
License data
Legal status
  • EU: Rx-only
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
Robenacoxib
Clinical data
Trade namesOnsior
Identifiers
DrugBank
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.210.035

References

  1. Gaynor JS, Muir WM (2014). "Robenacoxib". Handbook of Veterinary Pain Management (3rd, revised ed.). Elsevier Health Sciences. ISBN 9780323222143.
  2. Clark-Price S (2014). "Nonsteroidal anti-inflammatory drugs and corticosteroids: Robenacoxib". In Egger CM, Love L, Doherty T (eds.). Pain management in veterinary practice. Ames, Iowa: Wiley-Blackwell. ISBN 9781118761601.
  • "Robenacoxib". Drug Information Portal. U.S. National Library of Medicine.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.